Brief: Xbrane Biopharma Q1 EBITDA Loss Narrows To SEK 7.3 Million
May 14 (Reuters) - XBRANE BIOPHARMA AB XBRANE.ST :
* Q1 NET SALES SEK 8.6 MILLION VERSUS SEK 6.8 MILLION YEAR
AGO
* Q1 EBITDA LOSS SEK 7.3 MILLION VERSUS LOSS SEK 7.8 MILLION
YEAR
AGO
Source text for Eikon: ID:nGNEch73Jc
Further company coverage: XBRANE.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))